GlassScriptPhysician profile
Richard Zweig
NPI 1033135819
$4,092.20
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,421 · 2020: $706 · 2021: $903 · 2022: $62.39.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $700.60 | 2019-2021 | |
| Acadia Pharmaceuticals INC | $696.84 | 2019-2021 | |
| Amgen INC. | $362.23 | 2019-2021 | |
| Genzyme Corporation | $301.64 | 2019-2020 | |
| Abbvie INC. | $271.74 | 2021-2022 | |
| Biogen, INC. | $221.17 | 2019-2021 | |
| Emd Serono, INC. | $209.42 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $183.16 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $138.45 | 2019-2020 | |
| Portola Pharmaceuticals, LLC | $124.47 | 2020 | |
| Adamas Pharmaceuticals, INC. | $124.47 | 2019 | |
| Jazz Pharmaceuticals INC. | $114.98 | 2019 | |
| Acorda Therapeutics, INC | $98.09 | 2019 | |
| Neurocrine Biosciences, INC. | $87.10 | 2019-2021 | |
| Allergan, INC. | $73.84 | 2019-2020 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Greenwich Biosciences, INC. | $63.81 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $55.60 | 2021 | |
| Eisai INC. | $52.07 | 2019 | |
| Ge Healthcare | $39.62 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $39.38 | 2019 | |
| Avanir Pharmaceuticals, INC. | $31.08 | 2019 | |
| Horizon Therapeutics Plc | $29.20 | 2022 | |
| Sunovion Pharmaceuticals INC. | $23.58 | 2020 | |
| Csl Behring | $19.71 | 2019 | |
| Mallinckrodt Hospital Products INC. | $18.31 | 2021 | |
| Lilly USA, LLC | $11.64 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Zweig listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.